As the core implementers in the R&D, design, and manufacturing stages of medical devices, engineers’ depth of understanding of FDA regulations directly determines whether a product can enter the U.S. market smoothly and avoid compliance rework and regulatory penalties.

I. Core Regulatory Logic of the FDA: Risk-Based, Full Lifecycle Control

The FDA’s regulation of medical devices is based on the Federal Food, Drug, and Cosmetic Act (FD&C Act) and 21 CFR Federal Regulations , which is specifically implemented by the CDRH (Center for Devices and Radiological Health), with the core principle being The higher the risk, the stricter the regulation. . Regulatory coverage extends to products from Conceptual design, R&D validation, clinical testing, marketing authorization application, mass production, and product withdrawal The end-to-end process requires engineers to embed compliance thinking into every technical step and to maintain complete, traceable evidence.

II. Risk Grading: Engineers First Determine “Which Category” the Product Belongs To

FDA according to Patient risk, invasiveness, use cases Medical devices are classified into three categories, and this classification directly determines the R&D standards, testing requirements, and regulatory submission pathways, serving as the starting point for technical work.

Practical Operation Reminder for Engineers : In the early stages of R&D, classification must be confirmed through the FDA Product Code Database. Misclassification can lead to misaligned R&D priorities, failed regulatory submissions, and delayed product launches. 。

III. The Four Major Listing Paths: R&D Capabilities Must Align with Filing Requirements

Different pathways require different technical preparations; engineers must align with the registration team in advance to avoid having to conduct additional testing later. Xi'an Dewei Medical The simulation testing scheme can precisely align with the core technology verification requirements for each test path.

DeWei Medical Simulation Models—One-Piece Molding of Complex Vasculature, Precisely Simulating Human Vascular Anatomy and Functional Characteristics

1. 510(k) Premarket Notification (Class II Majority)

Core requirement: Demonstrate equivalence to a marketed “predicate device.” Substantial equivalence (Safety, performance, and technical specifications are consistent.)

Key engineering focuses: performance comparative testing, biocompatibility verification, and software validation—no large-scale clinical trials are required.

Medical value proposition: We offer a comprehensive product portfolio that includes endoscopic models, lower-extremity arterial calcification models, and 16-curve guidewire passability models. These products are reconstructed at a 1:1 scale based on authentic CT/MRI data, accurately replicating anatomical structures and physiological characteristics. This enables enterprises to swiftly conduct performance benchmarking against comparable products and efficiently generate substantiating data for demonstrating substantial equivalence.

2. PMA Premarket Approval (Class III Required)

Core requirement: Provide sufficient scientific evidence (including clinical trials) to demonstrate the device’s… Safe and effective 。

Key engineering priorities include comprehensive verification and validation, clinical trial design, and long-term stability testing; the volume of documentation is several times that required for a 510(k) submission.

Medical Value of DeWei: For cardiac assist devices and high-end implantable medical devices, we provide 3D-printed patient-specific organ models and customized testing systems that accurately replicate complex pathological conditions and physiological environments. These solutions support preclinical efficacy validation and clinical trial protocol design, thereby helping to ensure a comprehensive evidence chain for PMA submissions.

3. De Novo Innovation Pathway (Low-to-Moderate-Risk New Products Without Predicated Claims)

Core requirement: For innovative devices that have no comparable marketed products, submit a risk analysis and safety data; the FDA will determine the device classification within 120 days.

Key engineer focus: comprehensive risk analysis and bench-test data; once classified and approved, the product can be directly launched.

Medical Value of DeWei: Providing customized simulation testing solutions for innovative minimally invasive interventional devices, offering end-to-end support from risk assessment to model validation to help companies swiftly complete classification filing and technical verification.

4. Exemption Pathways (Primarily Class I)

Core requirement: Only general controls are required; no 510(k) or PMA is needed—market approval is granted directly.

Key focus for engineers: foundational quality control and the effective implementation of production standards.

Medical value of DeWei: Provides standardized, low-risk device testing models to meet basic compliance verification requirements.

IV. Quality Management System: The 2026 QMSR regulations will take effect, and engineers must adhere to the bottom line.

February 2, 2026, QMSR (Quality Management System Regulations) It officially replaces the previous QSR (21 CFR Part 820) and achieves full alignment with ISO 13485:2016, marking the most significant regulatory overhaul in nearly 30 years. Engineers must master the core changes.

Core Requirements

Control is exercised over the entire end-to-end process, from design and development through procurement, production, packaging, labeling, storage, and after-sales service, establishing Risk-Driven Quality System 。

Key Responsibilities of an Engineer

Design control: Ensure robust management of design inputs and outputs, reviews, verification, validation, and change control, and maintain complete design documentation.

Process Control: validation of manufacturing processes, equipment calibration, and quality control of raw materials;

Record Retention: All test, validation, and change records shall be traceable to support FDA on-site inspections.

Medical implementation support for virtue

Xi'an Dewei Medical As a supplier specializing in high-end medical testing equipment and specialized testing services, we can provide Professional Simulation Testing Solutions It covers end-to-end quality control requirements spanning the entire product lifecycle, from design verification to post-market surveillance. Its medical simulation models and testing systems comply with ISO 13485 and FDA QMSR regulations, helping organizations establish standardized testing procedures, maintain compliance documentation, and smoothly pass FDA quality system audits.

DeWei Medical Brain Parenchyma Model

V. The Four Mandatory Compliance Requirements That Engineers Must Adhere To

1. Design, Development, and Risk Management

Strictly enforce Design Control Process , each step of the output must be reviewed and approved to prevent “making changes while working”;

Conduct full-process risk analysis (FMEA) to identify and control risks throughout the design, manufacturing, and use phases.

Any design changes must undergo the approval process, be re-validated, and have change records maintained.

De Wei Medical provides support: through High-fidelity anatomical model Combined with customized testing solutions, we help engineers accurately identify design risks, optimize product architecture, and proactively mitigate compliance hazards.

2. Software and Cybersecurity (Mandatory in 2026)

Devices with software, network connectivity, and Bluetooth/USB interfaces, Mandatory cybersecurity verification ；

Submit the Software Bill of Materials (SBOM), vulnerability monitoring plan, and patch update schedule;

AI/ML devices must comply with the PCCP’s scheduled change management plan, and algorithm iterations must be submitted for regulatory approval in accordance with applicable regulations.

DeWei Medical Support: Provides a medical software development and testing system that supports software functional verification and cybersecurity penetration testing, thereby meeting FDA compliance requirements for medical software.

3. UDI Unique Identifier

All devices must be assigned a UDI and entered into the GUDID database.

UDI must be marked on the label, packaging, and the product itself to meet traceability requirements.

Supporting healthcare through expertise: Providing UDI compliance testing models to help enterprises complete label design and traceability validation, ensuring adherence to FDA UDI implementation requirements.

4. Post-Listing Regulation

Serious Adverse Event Report within 5 days FDA: General incidents must be reported within 30 days;

Coordinate with FDA recalls, post-market surveillance, and on-site inspections, and promptly address identified issues.

Empowering healthcare through excellence: We provide post-market testing and monitoring services to help companies continuously track product performance and respond swiftly to adverse events and regulatory requirements.

VI. Engineers’ Compliance Pitfalls: The 5 Most Common Traps

Classification was not confirmed during the early R&D phase, leading to a complete rework later due to non-compliance with standards.

Insufficient design verification and incomplete test data resulted in the denial of the 510(k)/PMA submission;

No records or verification were maintained for design changes, resulting in 483 deficiency items being identified during the on-site inspection.

Software and network security systems that have not been designed in compliance with regulations will be outright denied approval under the new rules effective in 2026.

Failure to comply with the new QMSR regulations and continued adherence to the old QSR will result in failure of the quality system audit.

VII. Summary: Core Compliance Mnemonics for Engineers

First, define the classification accurately and choose the right compliance pathway; embed compliance into R&D and maintain robust test documentation; uphold a robust QMSR system to manage risks throughout the entire lifecycle; prioritize software security and ensure seamless traceability; leverage digital simulation to enhance capabilities, and follow a clear FDA regulatory pathway to achieve smooth approval.

FDA regulations are not a straitjacket that stifles R&D; rather, they serve as a passport that ensures product safety and paves the way for market access in the United States. Leveraging its core technologies in 3D printing, hemodynamics, and medical simulation, as well as extensive experience in medical simulation, testing equipment, and medical software development, Xi’an Dewei Medical specializes in providing minimally invasive interventional simulation and testing solutions. These solutions help engineers achieve precision and regulatory compliance, thereby accelerating the rapid and stable entry of products into the world’s largest medical device market.

To the Reader:

For the latest updates and related information, please contact our official website customer service or follow “Xi’an Dewei” and “Dewei Medical” on WeChat, Douyin, Xiaohongshu, Bilibili, and other platforms. We offer professional consultation and customized services.